Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EVOLOCUMAB for Coronary artery disease: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 1,266 adverse event reports in the FDA FAERS database where EVOLOCUMAB was used for Coronary artery disease.

Most Reported Side Effects for EVOLOCUMAB

Side Effect Reports % Deaths Hosp.
Device difficult to use 31,807 21.3% 11 538
Drug dose omission by device 23,957 16.0% 7 327
Wrong technique in product usage process 21,664 14.5% 4 285
Accidental exposure to product 16,160 10.8% 3 154
Injection site pain 9,988 6.7% 3 154
Product storage error 6,606 4.4% 2 88
Back pain 5,254 3.5% 14 201
Myalgia 5,061 3.4% 15 177
Drug dose omission 4,914 3.3% 1 87
Injection site bruising 4,409 3.0% 1 83
Device use error 4,002 2.7% 0 76
Injection site haemorrhage 3,720 2.5% 1 50
Arthralgia 3,692 2.5% 10 175
Off label use 3,558 2.4% 23 153
Fatigue 3,506 2.3% 7 165

Other Indications for EVOLOCUMAB

Product used for unknown indication (60,696) Blood cholesterol increased (29,401) Hypercholesterolaemia (23,505) Blood cholesterol abnormal (13,116) Hyperlipidaemia (10,208) Type iia hyperlipidaemia (5,556) Low density lipoprotein increased (2,740) Arteriosclerosis (2,094) Type v hyperlipidaemia (1,816) Dyslipidaemia (1,056)

Other Drugs Used for Coronary artery disease

ASPIRIN (2,758) CLOPIDOGREL BISULFATE (1,584) ATORVASTATIN (891) RIVAROXABAN (847) DILTIAZEM (664) ROSUVASTATIN (600) TICAGRELOR (520) QUINAPRIL (511) AMLODIPINE (486) NITROGLYCERIN (421)

Related Pages

EVOLOCUMAB Full Profile All Coronary artery disease Drugs EVOLOCUMAB Demographics EVOLOCUMAB Timeline